Despite the substantial clinical importance of prostate cancer, the molecul
ar mechanisms underlying the development and progression of the disease are
poorly understood. The aim of molecular genetics is to reveal the genetic
alterations and genes that are involved in disease processes. Linkage analy
sis have already implicated four chromosomal loci that may harbour prostate
cancer susceptibility genes. In addition, chromosomal alterations in prost
ate tumors have been studied using several techniques, such as comparative
genomic hybridization. These analyses have indicated that losses of chromos
omes 6q, 8p, 10q, 13q, and 16q, as well as gains of 7, 8q, and Xq are parti
cularly common in prostate cancer. There is also a strong evidence, that ge
nes, such as androgen receptor gene (AR), e-cadherin, and PTEN, are involve
d in the development and progression of prostate cancer. However, the targe
t genes for most of the above mentioned chromosomal alterations as well as
the genes predisposing to prostate cancer have not been cloned yet. The ide
ntification of those genes should be the utmost goal of basic research of p
rostate cancer, today.